Pulmonology

Upper airway stimulation, a sleep apnea treatment on the rise, is showing particular benefit for female patients.

Early-stage study results from the multi-center MUST-ARDS trial show the ex-vivo adult progenitor cell-expanding therapy is capable of improving 28-day mortality, care burden, and overall safety in patients with ARDS.

Mental health disorders are highly prevalent in certain patients with COPD—and their effect can limit lung function therapy benefit.

Early research found that e-cigarette use affects the immune system response to the flu virus and the effects are different for female and male users.

A multivariate cohort showed opioids in situation of critical care may not drive rates of continued use after 1 year.

The intracellular tyrosine kinases inhibitor has a similar benefit for patients with the rare, heterogenous associated form of ILD as it does for patients with IPF.

Among patients in SINUS-24 and SINUS-52 with chronic rhinosinusitis with nasal polyps and comorbid asthma, dupilumab significantly improved function and patient-reported outcomes.

Does it matter whether federal and state regulations allow for a significant user population?

How new GRIPHON data showed further definitive long-term outcomes for patients with pulmonary hypertension.

Why are diagnoses still significantly underwhelming for a chronic condition on the rise?

High-risk LIVE scores for patients with COPD were associated with higher all-cause mortality and higher rates of referral to palliative care.

New Sunovion data at ATS 2019 shows expected trends of comorbidity effect on patients, and surprising results of care between men and women.

In an open-label trial among adults with mild asthma, budesonide-formoterol treatment was superior to albuterol for the prevention of asthma exacerbations.

Investigators were seeking an alternative therapy for persistent asthma patients reporting insufficient benefit from mometasone, despite it being the guideline standard.

New clinical findings go against the advisory of the GOLD 2017 classification.

Children with asthma who used the eAsthma Tracker app weekly missed 60% fewer days of school and their parents missed 70% fewer days of work.

Zebra Medical Vision received clearance for HealthPNX, an AI-based chest X-ray triage product.

Filters that break up the exhaust from diesel engines are intended to decrease the health impacts of heavy roadway traffic, but a new study suggests the opposite might be happening in some cases.

Most surveyed comorbid patients reported they required the help of family, friends or caregivers during pneumonia recovery, and needed an average of 28 days of care.

Findings from ASCENT-COPD show the long-acting muscarinic antagonist is noninferior to placebo in driving major adverse cardiovascular event risk in very at-risk patients with COPD.

The GSK triple-combination FF/UMEC/VI inhaler reported significant lung function improvement in patients with inadequately controlled asthma.

A new meta analysis speculates whether specialists or primary care physicians are the best clinicians to diagnose, treat, and manage COPD.

A major clinical challenge encountered by thoracic surgeons lies in the decision to pursue surgery, which must be weighed between surgical risk and the reliability of CT findings.

Some programs are governed by medical or radiation oncology departments, whereas others are led by pulmonology, radiology, pathology, or thoracic surgery departments, often in multidisciplinary combinations.

Most programs offer smoking cessation counseling as part of the shared decision making visit and throughout the program. Some LCS programs also order pulmonary function studies for new patients to provide an overall picture of lung health.